CONTRACT OPPORTUNITY RRPV Solicitation Summary: NextGen Vaccines: Immune Assays
Agency: | |
---|---|
Level of Government: | Federal |
Category: |
|
Opps ID: | NBD00159520971961042 |
Posted Date: | Feb 22, 2024 |
Due Date: | Mar 18, 2024 |
Source: | https://sam.gov/opp/66d6545a2e... |
- Contract Opportunity Type: Special Notice (Original)
- All Dates/Times are: (UTC-05:00) EASTERN STANDARD TIME, NEW YORK, USA
- Original Published Date: Feb 22, 2024 12:12 pm EST
- Original Response Date: Mar 18, 2024 01:00 pm EDT
- Inactive Policy: Manual
- Original Inactive Date: Mar 18, 2024
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: AN42 - Health R&D Services; Health Care - Other; Applied Research
-
NAICS Code:
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
-
Place of Performance:
Washington , DCUSA
This solicitation summary is to notify all potential offerors of a Request for Project Proposals (RPP) issued through the Rapid Response Partnership Vehicle (RRPV) Consortium on behalf of the Biomedical Advanced Research and Development Authority (BARDA) entitled, "NextGen Vaccines: Immune Assays". The purpose of this initiative is to establish multiparameter ICS assays to identify and quantify SARS-CoV-2-specific T-cell subsets in peripheral blood mononuclear cell (PBMC) samples. The full RPP and information on joining the consortium can be accessed through the RRPV website at www.rrpv.org.
- O’NEILL HOUSE OFFICE BUILDING
- WASHINGTON , DC 20515
- USA
- Rebecca Harmon
- rebecca.harmon@ati.org
- Feb 22, 2024 12:12 pm ESTSpecial Notice (Original)
TRY FOR FREE
Not a USAOPPS Member Yet?
Get unlimited access to thousands of active local, state and federal government bids and awards in All 50 States.